Zai Lab Limited (9688.HK)

HKD 20.5

(-3.76%)

Operating Expenses Summary of Zai Lab Limited

Zai Lab Limited's latest annual operating expenses in 2023 was 537.47 Million USD , down -0.06% from previous year.
Zai Lab Limited's latest quarterly operating expenses in 2024 Q2 was 140.8 Million USD , up 39.15% from previous quarter.
Zai Lab Limited reported a annual operating expenses of 545.37 Million USD in annual operating expenses 2022, down -31.15% from previous year.
Zai Lab Limited reported a annual operating expenses of 792.13 Million USD in annual operating expenses 2021, up 137.15% from previous year.
Zai Lab Limited reported a quarterly operating expenses of 123.83 Million USD for 2024 Q1, down -23.62% from previous quarter.
Zai Lab Limited reported a quarterly operating expenses of 127.31 Million USD for 2023 Q3, down -11.95% from previous quarter.

Annual Operating Expenses Chart of Zai Lab Limited (2023 - 2015)

Historical Annual Operating Expenses of Zai Lab Limited (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	537.47 Million USD	-0.06%
2022	545.37 Million USD	-31.15%
2021	792.13 Million USD	137.15%
2020	334.02 Million USD	57.24%
2019	212.43 Million USD	49.75%
2018	141.85 Million USD	176.03%
2017	51.39 Million USD	33.38%
2016	38.52 Million USD	135.66%
2015	16.34 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	140.8 Million USD	39.15%
2024 Q1	123.83 Million USD	-23.62%
2023 Q3	127.31 Million USD	-11.95%
2023 Q2	144.6 Million USD	30.29%
2023 FY	545.04 Million USD	-0.06%
2023 Q1	110.98 Million USD	-20.14%
2023 Q4	162.14 Million USD	27.35%
2022 Q1	110.84 Million USD	-54.13%
2022 FY	545.37 Million USD	-31.15%
2022 Q4	138.97 Million USD	-16.32%
2022 Q3	166.07 Million USD	28.26%
2022 Q2	129.48 Million USD	16.82%
2021 FY	792.13 Million USD	137.15%
2021 Q2	196.63 Million USD	-17.96%
2021 Q3	114.14 Million USD	-41.95%
2021 Q4	241.66 Million USD	111.71%
2021 Q1	239.69 Million USD	131.52%
2020 Q2	92.06 Million USD	75.51%
2020 Q3	85.97 Million USD	-6.62%
2020 FY	334.02 Million USD	57.24%
2020 Q4	103.52 Million USD	20.42%
2020 Q1	52.45 Million USD	-4.83%
2019 Q2	44.51 Million USD	0.0%
2019 FY	212.43 Million USD	49.75%
2019 Q4	55.11 Million USD	-19.99%
2019 Q3	68.89 Million USD	54.75%
2019 Q1	44.51 Million USD	-33.18%
2018 Q1	20.94 Million USD	59.88%
2018 Q2	20.94 Million USD	0.0%
2018 Q3	34.22 Million USD	63.39%
2018 Q4	66.62 Million USD	94.66%
2018 FY	141.85 Million USD	176.03%
2017 FY	51.39 Million USD	33.38%
2017 Q1	12.35 Million USD	-5.04%
2017 Q2	12.35 Million USD	0.0%
2017 Q3	13.1 Million USD	6.08%
2017 Q4	13.1 Million USD	0.0%
2016 Q4	13 Million USD	0.0%
2016 Q3	13 Million USD	118.65%
2016 Q1	5.94 Million USD	0.0%
2016 Q2	5.94 Million USD	-0.0%
2016 FY	38.52 Million USD	135.66%
2015 FY	16.34 Million USD	0.0%

Peer Operating Expenses Comparison of Zai Lab Limited

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-65.352%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	27.295%